Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 114.55
   
  • Change Today:
    $-3.31
  • 52 Week High: $121.40
  • 52 Week Low: $82.21
  • Currency: US Dollars
  • Shares Issued: 1,246.00m
  • Volume: 6,468,072
  • Market Cap: $142,729m
  • RiskGrade: 120

Latest ShareCast News

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

By Frank Prenesti

Date: Thursday 23 Feb 2023

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 114.55
Change Today $ -3.31
% Change -2.81 %
52 Week High $121.40
52 Week Low $82.21
Volume 6,468,072
Shares Issued 1,246.00m
Market Cap $142,729m
RiskGrade 120

What The Brokers Say

Strong Buy 9
Buy 12
Neutral 6
Sell 1
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 12-Sep-2025

Time Volume / Share Price
16:00 1,278,669 @ $114.55
15:59 1,347 @ $114.52
15:59 591 @ $114.52
15:59 200 @ $114.52
15:59 100 @ $114.52

Top of Page